vs

Side-by-side financial comparison of Graham Holdings Co (GHC) and Incyte (INCY). Click either name above to swap in a different company.

Incyte is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.0× Graham Holdings Co). Incyte runs the higher net margin — 23.8% vs 8.7%, a 15.1% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (19.8% vs 0.4%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 4.2%).

Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

GHC vs INCY — Head-to-Head

Bigger by revenue
INCY
INCY
1.0× larger
INCY
$1.3B
$1.3B
GHC
Growing faster (revenue YoY)
INCY
INCY
+19.3% gap
INCY
19.8%
0.4%
GHC
Higher net margin
INCY
INCY
15.1% more per $
INCY
23.8%
8.7%
GHC
Faster 2-yr revenue CAGR
INCY
INCY
Annualised
INCY
10.4%
4.2%
GHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GHC
GHC
INCY
INCY
Revenue
$1.3B
$1.3B
Net Profit
$108.7M
$303.3M
Gross Margin
Operating Margin
3.8%
23.7%
Net Margin
8.7%
23.8%
Revenue YoY
0.4%
19.8%
Net Profit YoY
-80.2%
91.7%
EPS (diluted)
$24.76
$1.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GHC
GHC
INCY
INCY
Q1 26
$1.3B
Q4 25
$1.3B
$1.5B
Q3 25
$1.3B
$1.4B
Q2 25
$1.2B
$1.2B
Q1 25
$1.2B
$1.1B
Q4 24
$1.2B
$1.2B
Q3 24
$1.2B
$1.1B
Q2 24
$1.2B
$1.0B
Net Profit
GHC
GHC
INCY
INCY
Q1 26
$303.3M
Q4 25
$108.7M
$299.3M
Q3 25
$122.9M
$424.2M
Q2 25
$36.7M
$405.0M
Q1 25
$23.9M
$158.2M
Q4 24
$548.8M
$201.2M
Q3 24
$72.5M
$106.5M
Q2 24
$-21.0M
$-444.6M
Gross Margin
GHC
GHC
INCY
INCY
Q1 26
Q4 25
92.0%
Q3 25
92.8%
Q2 25
93.5%
Q1 25
93.0%
Q4 24
92.5%
Q3 24
92.4%
Q2 24
92.7%
Operating Margin
GHC
GHC
INCY
INCY
Q1 26
23.7%
Q4 25
3.8%
22.3%
Q3 25
5.2%
32.5%
Q2 25
6.0%
43.6%
Q1 25
4.1%
19.5%
Q4 24
5.8%
25.6%
Q3 24
6.8%
12.8%
Q2 24
2.2%
-45.8%
Net Margin
GHC
GHC
INCY
INCY
Q1 26
23.8%
Q4 25
8.7%
19.9%
Q3 25
9.6%
31.1%
Q2 25
3.0%
33.3%
Q1 25
2.0%
15.0%
Q4 24
44.1%
17.1%
Q3 24
6.0%
9.4%
Q2 24
-1.8%
-42.6%
EPS (diluted)
GHC
GHC
INCY
INCY
Q1 26
$1.47
Q4 25
$24.76
$1.46
Q3 25
$27.91
$2.11
Q2 25
$8.35
$2.04
Q1 25
$5.45
$0.80
Q4 24
$124.05
$0.90
Q3 24
$16.42
$0.54
Q2 24
$-4.79
$-2.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GHC
GHC
INCY
INCY
Cash + ST InvestmentsLiquidity on hand
$267.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.8B
$5.6B
Total Assets
$8.4B
$7.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GHC
GHC
INCY
INCY
Q1 26
Q4 25
$267.0M
$3.1B
Q3 25
$190.8M
$2.5B
Q2 25
$176.2M
$2.0B
Q1 25
$156.7M
$1.9B
Q4 24
$260.9M
$1.7B
Q3 24
$244.4M
$1.3B
Q2 24
$140.7M
$987.3M
Stockholders' Equity
GHC
GHC
INCY
INCY
Q1 26
$5.6B
Q4 25
$4.8B
$5.2B
Q3 25
$4.5B
$4.7B
Q2 25
$4.4B
$4.2B
Q1 25
$4.3B
$3.7B
Q4 24
$4.3B
$3.4B
Q3 24
$4.0B
$3.2B
Q2 24
$4.0B
$3.0B
Total Assets
GHC
GHC
INCY
INCY
Q1 26
$7.3B
Q4 25
$8.4B
$7.0B
Q3 25
$7.9B
$6.3B
Q2 25
$7.6B
$5.8B
Q1 25
$7.6B
$5.7B
Q4 24
$7.7B
$5.4B
Q3 24
$7.4B
$5.0B
Q2 24
$7.2B
$4.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GHC
GHC
INCY
INCY
Operating Cash FlowLast quarter
$28.3M
Free Cash FlowOCF − Capex
$5.0M
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$275.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GHC
GHC
INCY
INCY
Q1 26
Q4 25
$28.3M
$543.3M
Q3 25
$178.1M
$559.4M
Q2 25
$94.8M
$44.7M
Q1 25
$46.0M
$266.1M
Q4 24
$116.3M
$381.2M
Q3 24
$237.6M
$310.9M
Q2 24
$52.0M
$-575.6M
Free Cash Flow
GHC
GHC
INCY
INCY
Q1 26
Q4 25
$5.0M
Q3 25
$161.8M
Q2 25
$78.0M
Q1 25
$30.5M
Q4 24
$91.1M
Q3 24
$219.4M
Q2 24
$33.7M
FCF Margin
GHC
GHC
INCY
INCY
Q1 26
Q4 25
0.4%
Q3 25
12.6%
Q2 25
6.4%
Q1 25
2.6%
Q4 24
7.3%
Q3 24
18.2%
Q2 24
2.8%
Capex Intensity
GHC
GHC
INCY
INCY
Q1 26
Q4 25
1.9%
Q3 25
1.3%
Q2 25
1.4%
Q1 25
1.3%
Q4 24
2.0%
Q3 24
1.5%
Q2 24
1.5%
Cash Conversion
GHC
GHC
INCY
INCY
Q1 26
Q4 25
0.26×
1.82×
Q3 25
1.45×
1.32×
Q2 25
2.58×
0.11×
Q1 25
1.93×
1.68×
Q4 24
0.21×
1.89×
Q3 24
3.28×
2.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GHC
GHC

Products$602.7M48%
Kaplan International$251.9M20%
Manufacturing$117.8M9%
Television Broadcasting$110.5M9%
Higher Education$83.8M7%
Supplemental Education$74.9M6%
Related Party$4.4M0%

INCY
INCY

Segment breakdown not available.

Related Comparisons